Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage
- PMID: 1778203
- DOI: 10.1007/BF00180412
Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage
Abstract
The entry of autologous iodine-125 low density lipoprotein (125I-LDL) into the aortic wall in rabbits was measured. After abdominal endothelium abrasion with a Fogarthy catheter the animals were fed a 1% cholesterol-supplemented diet for 4 weeks. The animals were killed 1-48 h after administration of 25 muCi 125I-LDL. Local entry of radiolabelled LDL was estimated and correlated to endothelial surface lining and foam cell content, both controlled morphologically. Endothelialized segments showed the lowest entry of 125I-LDL, the maximum uptake was reached at around 8 h. In de-endothelialized segments the entry was higher and the peak later (12 h), while in re-endothelialized segments a continuous increase in 125I-LDL entry up to 48 h was measured. Number and extent of foam cells correlated with the entry of LDL. The data indicate the usefulness of LDL radiolabelling for qualitative in vivo information on surface lining and foam cell content.
Similar articles
-
Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage.Eur J Nucl Med. 1991;18(12):948-51. doi: 10.1007/BF00180413. Eur J Nucl Med. 1991. PMID: 1778204
-
Prostaglandin E1 decreases the low-density-lipoprotein entry into rabbit arterial wall.Br J Pharmacol. 1991 Jul;103(3):1626-8. doi: 10.1111/j.1476-5381.1991.tb09838.x. Br J Pharmacol. 1991. PMID: 1933127 Free PMC article.
-
Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation.Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):641-9. doi: 10.1161/01.atv.18.4.641. Arterioscler Thromb Vasc Biol. 1998. PMID: 9555871
-
Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.Toxicol Pathol. 1990;18(4 Pt 1):560-71. Toxicol Pathol. 1990. PMID: 2091235 Review.
-
Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis.Histol Histopathol. 1998 Jul;13(3):797-817. doi: 10.14670/HH-13.797. Histol Histopathol. 1998. PMID: 9690137 Review.
Cited by
-
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.Theranostics. 2011 Jan 18;1:58-82. doi: 10.7150/thno/v01p0058. Theranostics. 2011. PMID: 21547153 Free PMC article.
-
Radionuclide imaging: a molecular key to the atherosclerotic plaque.J Am Coll Cardiol. 2008 Jul 1;52(1):1-12. doi: 10.1016/j.jacc.2008.03.036. J Am Coll Cardiol. 2008. PMID: 18582628 Free PMC article. Review.
-
Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview.Curr Med Chem. 2009;16(12):1499-511. doi: 10.2174/092986709787909596. Curr Med Chem. 2009. PMID: 19355903 Free PMC article. Review.
-
Targeting the vulnerable plaque: the evolving role of nuclear imaging.J Nucl Cardiol. 2005 Mar-Apr;12(2):234-46. doi: 10.1016/j.nuclcard.2005.01.008. J Nucl Cardiol. 2005. PMID: 15812381 Review.
-
Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury.Eur J Nucl Med. 1993 Dec;20(12):1141-5. doi: 10.1007/BF00171011. Eur J Nucl Med. 1993. PMID: 8299648